miscsubjectsAI governance
Evidence review

SS-31 for Stimulant Load: Mitochondrial Support in a Multi-Peptide Stack

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-stimulants`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-stimulants

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-stimulants/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-stimulants/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-stimulants/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Stimulant load (Adderall / amphetamine)

  1. Amphetamines force dopamine and norepinephrine release — borrow focus now.
  2. Sleep, appetite, and gut lining often suffer — less regeneration window.
  3. Chronic load can deplete neurochemistry and stress the gut-brain axis.

Layers:

  • Dopamine system: Forced release → depletion → crash, anhedonia, tolerance.
  • Sleep: Stimulants delay sleep onset and cut deep sleep.
  • Gut: Stimulants stress mucosa; gut inflammation affects mood and cognition.
  • Anxiety: Arousal without calm → jitter, rumination, non-restorative stress.

Why Semax might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.
  3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.
  4. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.

Why Selank might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Layer breaking down: Anxiety — Arousal without calm → jitter, rumination, non-restorative stress.
  3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
  4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

Why DSIP might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Layer breaking down: Sleep — Stimulants delay sleep onset and cut deep sleep.
  3. What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion.
  4. Therefore for you: If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.

Why SS-31 (Elamipretide) might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

Why Amphetamine stimulants matters for you

  1. Drug: Amphetamine stimulants
  2. What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Neural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.

  • Semax → neural / cognitive
  • Selank → anxiety / neurochemistry
  • DSIP → sleep / repair window
  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 3
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.46 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice (source s1)

Mouse study showing mitochondrial protection against inflammation-induced dysfunction.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome (source s2)

Review proposing Semax for ADHD based on rodent dopamine and BDNF data.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety (source s3)

Rodent and clinical context for Selank anxiolytic action without typical benzo drawbacks.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

DSIP reduces amphetamine-induced hyperthermia in mice (source s4)

1984 mouse study on DSIP and amphetamine thermoregulation.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Peptide components (collapsible embeds)

Semax: BDNF Upregulation · neural / cognitive · semax
{
  "peptide": "semax",
  "regenerative_layer": "neural / cognitive",
  "targets_this_degeneration": "BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.",
  "proposed_regeneration": "Studied for BDNF and neural support — building connections, not sedating symptoms.",
  "evidence_in_ledger": {
    "human_claims": 8,
    "preclinical_claims": 6,
    "anecdote_claims": 68,
    "studies_catalogued": 32
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/semax"
}

Overview Semax is described as a brain peptide that upregulates BDNF. Preclinical Evidence (Rat Studies) In rat hippocampus, a single intranasal dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by increased trkB phosphorylation and mRNA expression (preclinical tier). [Do…

Full semax article →
Selank: Non-Sedating Anxiolytic · anxiety / neurochemistry · selank
{
  "peptide": "selank",
  "regenerative_layer": "anxiety / neurochemistry",
  "targets_this_degeneration": "Chronic stress chemistry, stimulant jitter, non-restorative arousal.",
  "proposed_regeneration": "Studied for anxiolytic pathways without classic benzodiazepine sedation.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 8,
    "anecdote_claims": 60,
    "studies_catalogued": 31
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/selank"
}

Overview Selank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties. Human Data A 2008 randomized study compared intranasal Selank to medazepam in 62 patients with generalized anxiety disorder and neurasthenia. Preclinical Data Rat studies show alterations in gene expression related to …

Full selank article →
DSIP: Natural Deep Sleep · sleep / repair window · dsip
{
  "peptide": "dsip",
  "regenerative_layer": "sleep / repair window",
  "targets_this_degeneration": "Lost deep sleep — when growth hormone and tissue repair cycles run.",
  "proposed_regeneration": "Studied for sleep architecture and deep-sleep promotion.",
  "evidence_in_ledger": {
    "human_claims": 9,
    "preclinical_claims": 4,
    "anecdote_claims": 72,
    "studies_catalogued": 26
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/dsip"
}

Evidence-Graded Overview DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide first isolated from rabbit cerebral venous blood. Preclinical studies in multiple species have examined its association with slow-wave sleep. Preclinical Data (Animal and Cell Studies) Rat studies link endogenous DSIP to slow-wave sleep (SWS)…

Full dsip article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

stimulants · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain c33ba355e593 · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
preclinical
SS-31 targets cardiolipin to support mitochondrial electron transport and reduce ROS in preclinical models.
sources: s1
preclinical
Semax elevates BDNF and modulates dopamine in rodent studies; potential adjunct noted in ADHD hypotheses.
sources: s2
preclinical
DSIP reduced amphetamine-induced hyperthermia in 1980s mouse studies.
sources: s4
humanlow confidence
Selank showed anxiolytic effects comparable to benzodiazepines in small Russian human studies without sedation.
sources: s3
humanlow confidence
Elamipretide received FDA approval in 2025 for Barth syndrome, a rare mitochondrial disorder.
sources: s5
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:46
SS-31 for Stimulant Load: Mitochondrial Support in a Multi-Peptide Stack · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Stimulants
Slug: ss-31-stimulants
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"multi_stack","condition":"Stimulant load (Adderall / amphetamine)","condition_key":"adderall-stimulant","primary_peptide":null,"peptides_in_scope":[{"id":"semax","name":"Semax"},{"id":"selank","name":"Selank"},{"id":"dsip","name":"DSIP"},{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in
it output
{
  "slug": "ss-31-stimulants",
  "title": "SS-31 for Stimulant Load: Mitochondrial Support in a Multi-Peptide Stack",
  "body": "## What's breaking down if you have Stimulant load (Adderall / amphetamine)\n\nAmphetamines force dopamine and norepinephrine release. This borrows focus now.\n\nSleep, appetite, and gut lining often suffer. That shortens the regeneration window.\n\nChronic load can deplete neurochemistry and stress the gut-brain axis.\n\nDegenerative layers include:\n\n- Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.\n- Sleep: Stimulants delay sleep onset and reduce deep sleep.\n- Gut: Stress on mucosa; inflammation affects mood and cognition.\n- Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.\n\nBreakdown outruns repair. The condition persists when repair pathways stay under-supported.\n\n## Why Semax might help you\n\n1. You have Stimulant load (Adderall / amphetamine). Breakdown is outpacing repair.\n2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\n3. What Semax is studied to do: Studied for BDNF and neural support. It builds connections rather than sedating symptoms.\n4. Therefore for you: If the neural/cognitive layer is part of your problem, Semax is discussed because it targets repair, not because it masks signals.\n\n## Why
69579dc44bb96551
Machine verification: /api/articles/ss-31-stimulants/contributions
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "SS-31 targets cardiolipin to support mitochondrial electron transport and reduce ROS in preclinical models."?
ask ss-31-stimulants claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Semax elevates BDNF and modulates dopamine in rodent studies; potential adjunct noted in ADHD hypotheses."?
ask ss-31-stimulants claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "DSIP reduced amphetamine-induced hyperthermia in 1980s mouse studies."?
ask ss-31-stimulants claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "Selank showed anxiolytic effects comparable to benzodiazepines in small Russian human studies without sedation."?
ask ss-31-stimulants claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Elamipretide received FDA approval in 2025 for Barth syndrome, a rare mitochondrial disorder."?
ask ss-31-stimulants claim c5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 for Stimulant Load: Mitochondrial Support in a Multi-Peptide Stack — and what would you need me to tell you first?
ask ss-31-stimulants condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 for Stimulant Load: Mitochondrial Support in a Multi-Peptide Stack (studies vs anecdotes)?
ask ss-31-stimulants good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…